Abstract withdrawn
- PDF / 66,068 Bytes
- 1 Pages / 595.28 x 793.7 pts Page_size
- 82 Downloads / 233 Views
ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY
MEETING ABSTRACT
Open Access
Treatment costs associated with hospital-based intravenous immunoglobulin therapy compared to home-based subcutaneous immunoglobulin therapy in a cohort of paediatric patients with primary immunodeficiency Thierry Ducruet1, Marie-Claude Levasseur2, Anne Des Roches2, Renée Dicaire2, Elie Haddad2* From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2011 Quebec, Canada. 20-23 October 2011 Objectives To assess the direct and indirect costs associated with hospital-based IVIg therapy compared to home-based SCIg in a cohort of patients with PID from hospital/ government and family perspectives. Methods This is a retrospective study on a cohort of patients with PID. Annual costs associated with IVg therapy were assessed for each patient for the year prior to commencing home-based subcutaneous SCIg therapy and the year after for the costs associated with the SCIg therapy. Demographic and clinical information were collected from patient’s chart. Economic data were captured from administrative databases, patients, families, and healthcare providers. Paired t-tests and non-parametric Wilcoxon tests were used to assess the difference in costs.
government and family perspectives: -$ 2,602 (p
Data Loading...
